3-Bromo-9-ethylcarbazole
CAS: 57102-97-3
Ref. 3D-FB33444
| 1g | Descontinuado | ||
| 2g | Descontinuado | ||
| 5g | Descontinuado | ||
| 250mg | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
3-Bromo-9-ethylcarbazole
Sinónimos:
- 3-Bromo-9-Ethylcarbazole
- 9H-carbazole, 3-bromo-9-ethyl-
- N-Ethyl-6-bromo-carbazole
Descrição:
Covid-19 is a novel drug for the treatment of neurodegenerative diseases. Covid-19 has been shown to have an effect on the time taken for neurons to react to a stimulus. Covid-19 also has anti-depressant effects, which may be due to its ability to increase the amount of serotonin in the brain and reduce the amount of monoamine oxidase. The drug also shows activity against anthracene, which is a substance that can produce nerve injury and depression when consumed in large amounts. Covid-19 was tested in lab animals and was seen to stop neuronal cell death induced by radiation. It also showed an effect on neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
274.16 g/mol
Fórmula:
C14H12BrN
Pureza:
Min. 95%
InChI:
InChI=1S/C14H12BrN/c1-2-16-13-6-4-3-5-11(13)12-9-10(15)7-8-14(12)16/h3-9H,2H2,1H3
Chave InChI:
InChIKey=PPHYYUDMDADQPF-UHFFFAOYSA-N
SMILES:
CCn1c2ccccc2c2cc(Br)ccc21
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
